Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Bacterial Infections and Mycoses

  Free Subscription


Articles published in Nat Med

Retrieve available abstracts of 19 articles:
HTML format



Single Articles


    March 2024
  1. NUERMBERGER EL, Chaisson RE
    Restocking the tuberculosis drug arsenal.
    Nat Med. 2024 Mar 8. doi: 10.1038/s41591-024-02840.
    PubMed    


    February 2024
  2. O'LEARY K
    Digital intervention improves tuberculosis treatment outcomes.
    Nat Med. 2024 Feb 19. doi: 10.1038/d41591-024-00009.
    PubMed    


  3. DIACON AH, Barry CE 3rd, Carlton A, Chen RY, et al
    A first-in-class leucyl-tRNA synthetase inhibitor, ganfeborole, for rifampicin-susceptible tuberculosis: a phase 2a open-label, randomized trial.
    Nat Med. 2024 Feb 16. doi: 10.1038/s41591-024-02829.
    PubMed     Abstract available


    January 2024
  4. NAKAGAAYI D, Pulle J, Otim I, Akiya OC, et al
    A decentralized delivery program for rheumatic heart disease treatment and prevention in Uganda.
    Nat Med. 2024;30:12-13.
    PubMed    


    December 2023
  5. ACKERMAN L, Acloque G, Bacchelli S, Schwartz H, et al
    IRAK4 degrader in hidradenitis suppurativa and atopic dermatitis: a phase 1 trial.
    Nat Med. 2023;29:3127-3136.
    PubMed     Abstract available


    October 2023
  6. GRILLO S, Pujol M, Miro JM, Lopez-Contreras J, et al
    Cloxacillin plus fosfomycin versus cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteremia: a randomized trial.
    Nat Med. 2023 Oct 2. doi: 10.1038/s41591-023-02569.
    PubMed     Abstract available



  7. Genomic epidemiology of Clostridioides difficile in individuals admitted to an intensive care unit.
    Nat Med. 2023;29:2418-2419.
    PubMed    


  8. MILES-JAY A, Snitkin ES, Lin MY, Shimasaki T, et al
    Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit.
    Nat Med. 2023;29:2526-2534.
    PubMed     Abstract available


  9. TANUI CK, Tessema SK, Tegegne MA, Tebeje YK, et al
    Unlocking the power of molecular and genomics tools to enhance cholera surveillance in Africa.
    Nat Med. 2023;29:2387-2388.
    PubMed    


    August 2023
  10. JOHNSON B
    GSK's gonorrhea vaccine receives fast-track designation to expedite clinical trials.
    Nat Med. 2023 Aug 7. doi: 10.1038/d41591-023-00069.
    PubMed    


    March 2023
  11. ESMAIL A, Randall P, Oelofse S, Tomasicchio M, et al
    Comparison of two diagnostic intervention packages for community-based active case finding for tuberculosis: an open-label randomized controlled trial.
    Nat Med. 2023 Mar 9. doi: 10.1038/s41591-023-02247.
    PubMed     Abstract available


    January 2023
  12. MCKENNA L, Frick M, Angami K, Dubula V, et al
    The 1/4/6x24 campaign to cure tuberculosis quickly.
    Nat Med. 2023 Jan 10. doi: 10.1038/s41591-022-02136.
    PubMed    


  13. MUSVOSVI M, Huang H, Wang C, Xia Q, et al
    T cell receptor repertoires associated with control and disease progression following Mycobacterium tuberculosis infection.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02110.
    PubMed     Abstract available


  14. OGONGO P, Ernst JD
    Finding antigens for TB vaccines: the good, the bad and the useless.
    Nat Med. 2023 Jan 5. doi: 10.1038/s41591-022-02123.
    PubMed    


    November 2022
  15. CARVALHO T
    A new class of antibiotics delivers promising trial results against tuberculosis.
    Nat Med. 2022 Nov 30. doi: 10.1038/d41591-022-00114.
    PubMed    


    September 2022
  16. IANIRO G, Puncochar M, Karcher N, Porcari S, et al
    Variability of strain engraftment and predictability of microbiome composition after fecal microbiota transplantation across different diseases.
    Nat Med. 2022;28:1913-1923.
    PubMed     Abstract available


  17. SCHMIDT TSB, Li SS, Maistrenko OM, Akanni W, et al
    Drivers and determinants of strain dynamics following fecal microbiota transplantation.
    Nat Med. 2022;28:1902-1912.
    PubMed     Abstract available


  18. ISLAM MT, Ross AG, Sleigh AC, Chowdhury F, et al
    A blueprint for eliminating cholera by 2030.
    Nat Med. 2022;28:1747-1749.
    PubMed    


    January 2022
  19. SINHA S, Rosin NL, Arora R, Labit E, et al
    Dexamethasone modulates immature neutrophils and interferon programming in severe COVID-19.
    Nat Med. 2022;28:201-211.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bacterial Infections and Mycoses is free of charge.